Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 16, 2017

View Archived Issues

TREOS Bio raises funds to support clinical trial of colorectal cancer vaccine

Aequus Pharmaceuticals completes dosing in POC trial of AQS-1301

Allergan to acquire ZELTIQ

Viking Therapeutics reaches funding agreement for clinical development of VK-2809

Consortium of private investors acquires NexImmune

Surrozen closes series A financing

X-Chem, Janssen expand inflammatory disease collaboration

Insys Therapeutics provides cannabidiol oral solution for compassionate use studies

Boehringer Ingelheim and Weill Cornell Medicine enter COPD collaboration

FDA approves Siliq for plaque psoriasis

Phase III data show non-inferiority of doravirine and darunavir/ritonavir

Parsabiv launched in Japan

NCI grant supports breast cancer ADC research at Scripps Research Institute

Promising phase III results of UX-003 in patients with MPS VII

Clinical data reported for Fabry's disease candidate lucerastat

Chong Kun Dang Holdings divulges novel HDAC6 inhibitors

Hetero Research Foundation patents antiviral agents

Nanchang Helioeast identifies novel JAK inhibitors

ALK seeks European approval for ragweed sublingual allergy immunotherapy

Laboratorio Farmaceutico CT Srl patents ROS production inhibitors

Taiho Pharmaceutical discovers JAK3 inhibitors

Vedanta Biosciences collaborates with Stanford University and Leiden University

Roche discloses new mGlu4 receptor positive allosteric modulators

Amunix Operating enters R&D collaboration with Genentech

Tapimmune's phase II study of TPIV-200 in TNBC cleared to continue

Cytori Therapeutics completes acquisition of Azaya Therapeutics

Daiichi Sankyo conducts Japanese phase I trial of DS-1001b in IDH1 mutated gliomas

Daiichi Sankyo's DS-3032b receives U.S. orphan designation for liposarcoma

New mouse model of Staphylococcus aureus vascular graft infection developed

FDA designates Nuedexta an orphan drug for amyotrophic lateral sclerosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...